Ifosfamide studies for primary or recurrent pediatric malignant solid tumors and leukemia.
Ongoing studies using ifosfamide with mesna for primary or recurrent pediatric malignancies are reviewed. These studies include evaluations of ifosfamide given before conventional agents, in combination with other agents, with other effective agents and radiation therapy, and in alternative schedules.
Department of Hematology-Oncology, St Jude Children's Research Hospital, Memphis, TN 38101-0318.
C B
CB
Pratt
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D012008:Recurrence
D007069:Ifosfamide